# China NMPA Drug Inspection - Hubei Ruizhe Pharmaceutical Co., Ltd. - Doxophylline for Injection

Source: https://www.globalkeysolutions.net/records/china_drug_inspection/hubei-ruizhe-pharmaceutical-co-ltd/42643bcc-32be-47e3-b39e-3951c9fe8e92/
Source feed: China

> China NMPA drug inspection for Hubei Ruizhe Pharmaceutical Co., Ltd. published September 21, 2018. Drug: Doxophylline for Injection. 

---

## Details

- Record Type: CHINA_DRUG_INSPECTION
- Title: Jiangxi Province 2018 Drug Quality Bulletin
- Company Name: Hubei Ruizhe Pharmaceutical Co., Ltd.
- Publication Date: 2018-09-21
- Drug Name: Doxophylline for Injection

Company: https://www.globalkeysolutions.net/companies/hubei-ruizhe-pharmaceutical-co-ltd/c896b6af-3423-409e-9d2e-94c5db564b45/
